Regulation of angiogenesis by hypoxia: role of the HIF system
The DOI matches its Crossref record, with a small difference in title or year; 121 of the 121 references it cites were found in a registry or an index.
Abstract
The regulation of angiogenesis by hypoxia is an important component of homeostatic mechanisms that link vascular oxygen supply to metabolic demand. Molecular characterization of angiogenic pathways, identification of hypoxia-inducible factor (HIF) as a key transcriptional regulator of these molecules, and the definition of the HIF hydoxylases as a family of dioxygenases that regulate HIF in accordance with oxygen availability have provided new insights into this process. Here we review these findings, and the role of HIF in developmental, adaptive and neoplastic angiogenesis. We also discuss the implications of oncogenic activation of extensive, physiologically interconnected hypoxia pathways for the tumor phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationSemenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Self-citation
Cited by
Items 501–600 of 1,008
Combination of nanotechnology with vascular targeting agents for effective cancer therapy
Jahanban‐Esfahlan, R., Seidi, K., Banimohamad‐Shotorbani, B., Jahanban‐Esfahlan, A., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26051 · Cited by 84
Genomic signatures of high-altitude adaptation in Ethiopian sheep populations
Edea, Z., Dadi, H., Dessie, T., & Kim, K. (2019) · Genes & Genomics · doi:10.1007/s13258-019-00820-y · Cited by 96
Erdélyi, K., Ditrói, T., Johansson, H. J., Czikora, Á., Balog, N., Silwal‐Pandit, L., Ida, T., Olasz, J., Hajdú, D., Mátrai, Z., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100050118 · Cited by 91
Wu, H., Liang, X., Fang, Y., Qin, X., Zhang, Y., & Liu, J. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.06.036 · Cited by 92
Piret, J., Lecocq, C., Toffoli, S., Ninane, N., Raes, M. J., & Michiels, C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.024 · Cited by 96
Tavakkoli, A., Ahmadi, A., Razavi, B. M., & Hosseinzadeh, H. (2017) · PubMed Central · Cited by 116
Zirath, H., Rothbauer, M., Spitz, S., Bachmann, B., Jordan, C., Müller, B., Ehgartner, J., Priglinger, E., Mühleder, S., Redl, H. R., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00815 · Cited by 93
Davie, N. J., Gerasimovskaya, E. V., Hofmeister, S. E., Richman, A. P., Jones, P. L., Reeves, J. Τ., & Stenmark, K. R. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050754 · Cited by 85
Soluble nickel inhibits HIF‐prolyl‐hydroxylases creating persistent hypoxic signaling in A549 cells
Davidson, T. L., Chen, H., Di Toro, D. M., D'Angelo, G., & Costa, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20176 · Cited by 83
In vitro and ex vivo retina angiogenesis assays
Rezzola, S., Belleri, M., Gariano, G., Ribatti, D., Costagliola, C., Semeraro, F., & Presta, M. (2013) · Angiogenesis · doi:10.1007/s10456-013-9398-x · Cited by 94
Preterm Birth and Hypertension Risk: The Oxidative Stress Paradigm
Sutherland, M. R., Bertagnolli, M., Lukaszewski, M., Huyard, F., Yzydorczyk, C., Luu, T. M., & Nuyt, A. M. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01276 · Cited by 105
Green, M., Hiley, C. T., Shanks, J. H., Bottomley, I., West, C., Cowan, R. A., & Stratford, I. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.08.077 · Cited by 83
MYC and HIF in shaping immune response and immune metabolism
Gnanaprakasam, J. R., Sherman, J. W., & Wang, R. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.03.004 · Cited by 86
Nanozyme‐Enabled Treatment of Cardio‐ and Cerebrovascular Diseases
Zhang, Y., Liu, W., Wang, X., Liu, Y., & Wei, H. (2022) · Small · doi:10.1002/smll.202204809 · Cited by 90
Chakraborty, S., Adhikary, A., Mazumdar, M., Mukherjee, S., Bhattacharjee, P., Guha, D., Choudhuri, T., Chattopadhyay, S., Sa, G., Sen, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099743 · Cited by 83
Shibata, A., Nakagawa, K., Sookwong, P., Tsuduki, T., Tomita, S., Shirakawa, H., Komai, M., & Miyazawa, T. (2008) · Journal of Nutrition · doi:10.3945/jn.108.093237 · Cited by 83
Growth factor-induced therapeutic angiogenesis in the heart: protein therapy
Annex, B. H., & Simons, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.004 · Cited by 92
Functional Immune Cell‐Derived Exosomes Engineered for the Trilogy of Radiotherapy Sensitization
Ma, X., Yao, M., Gao, Y., Yue, Y., Li, Y., Zhang, T., Nie, G., Zhao, X., & Liang, X. (2022) · Advanced Science · doi:10.1002/advs.202106031 · Cited by 82
Medical Therapy in Peripheral Artery Disease
Berger, J. S., & Hiatt, W. R. (2012) · Circulation · doi:10.1161/circulationaha.111.033886 · Cited by 82
Accelerated host angiogenesis and immune responses by ion release from mesoporous bioactive glass
Zhou, Y., Han, S., Xiao, L., Han, P., Wang, S., He, J., Chang, J., Wu, C., & Xiao, Y. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00683k · Cited by 82
Hong, G.-H., Li, J.-W., Wei, W.-Q., Wu, Y., Li, L., Chen, Y.-B., Xie, D.-L., Qu, Q., Rojas, O. J., Hu, G.-Z., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c17291 · Cited by 81
Hypoxia-inducible factors in OSCC
Pérez‐Sayáns, M., Peñaranda, J. M. S., Pilar, G.-D., Barros, F., Gándara-Rey, J. M., & García, A. G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.08.017 · Cited by 84
Iron Homeostasis and Its Interaction with Prolyl Hydroxylases
Mole, D. R. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2790 · Cited by 82
Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease
Rychli, K., Huber, K., & Wojta, J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903241641 · Cited by 86
Estrogen-IGF-1 interactions in neuroprotection: Ischemic stroke as a case study
Sohrabji, F. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.05.003 · Cited by 81
Xu, Y., Zuo, Y., Zhang, H., Kang, X., Fei, Y., Yi, Z., Liu, M., Yeh, E. T. H., Chen, G., & Cheng, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164236 · Cited by 86
Bhang, S. H., Cho, S., Lim, J. M., Kang, J. M., Lee, T., Yang, H. S., Song, Y. S., Park, M. H., Kim, H.-S., Yoo, K., et al. (2009) · Stem Cells · doi:10.1002/stem.115 · Cited by 84
Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments
Wang, W., Zheng, H., Jiang, J., Li, Z., Jiang, D., Shi, X., Wang, H., Jiang, J., Xie, Q., Gao, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32066-w · Cited by 87
Rasheed, S., Harris, A. L., Tekkis, P. P., Turley, H., Silver, A., McDonald, P. J., Talbot, I. C., Glynne-Jones, R., Northover, J. M. A., & Guenther, T. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605026 · Cited by 81
Chen, M., Lee, C.-F., Huang, W., & Chou, T. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.009 · Cited by 80
The head ofBartonellaadhesin A is crucial for host cell interaction ofBartonella henselae
Kaiser, P. O., Rieß, T., Wagner, C. L., Linke, D., Lupas, A. N., Schwarz, H., Raddatz, G., Schäfer, A., & Kempf, V. A. J. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01201.x · Cited by 83
Techniques and assays for the study of angiogenesis
Irvin, M., Zijlstra, A., Wikswo, J. P., & Pozzi, A. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214529386 · Cited by 91
A perspective on the role of class III semaphorin signaling in central nervous system trauma
Mecollari, V., Nieuwenhuis, B., & Verhaagen, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00328 · Cited by 79
Scarpino, S., d’Alena, F. C., Napoli, A. D., Pasquini, A., Marzullo, A., & Ruco, L. (2004) · The Journal of Pathology · doi:10.1002/path.1522 · Cited by 79
Song, H., Yin, D., & Liu, Z. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1182-7 · Cited by 82
Asikainen, T. M., Chang, L.-Y., Coalson, J. J., Schneider, B. K., Waleh, N. S., Ikegami, M., Shannon, J. M., Winter, V. T., Grubb, P. H., Clyman, R. I., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5887fje · Cited by 79
Natale, G., & Bocci, G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.002 · Cited by 83
Viemann, D., Schmidt, M., Tenbrock, K., Schmid, S., Müller, V. A., Klimmek, K., Ludwig, S., Roth, J., & Goebeler, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3198 · Cited by 87
Ely, B. R., Lovering, A. T., Horowitz, M., & Minson, C. T. (2014) · Temperature · doi:10.4161/temp.29800 · Cited by 98
Riddell, J. R., Maier, P. G., Sass, S. N., Moser, M. T., Foster, B. A., & Gollnick, S. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050394 · Cited by 79
Lee, S., Moskowitz, M. A., & Sims, J. R. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.3.445 · Cited by 82
Licht, A. H., Müller-Holtkamp, F., Flamme, I., & Breier, G. (2006) · Blood · doi:10.1182/blood-2005-07-3033 · Cited by 78
Zhang, K., Li, S., Wang, J., Yan, S., Li, G., Cui, L., & Yin, J. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.043 · Cited by 87
FOXC1, the new player in the cancer sandbox
Elian, F., Yan, E., & Walter, M. A. (2017) · Oncotarget · doi:10.18632/oncotarget.22742 · Cited by 84
Liu, F.-Y., Fan, D., Yang, Z., Tang, N., Guo, Z., Ma, S., Ma, Z., Wu, H., Deng, W., & Tang, Q. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1718-7 · Cited by 82
Acute Kidney Injury by Ischemia/Reperfusion and Extracellular Vesicles
Nørgård, M. Ø., & Svenningsen, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015312 · Cited by 83
ELAVL1 regulates alternative splicing of eIF4E transporter to promote postnatal angiogenesis
Chang, S.-H., Elemento, O., Zhang, J., Zhuang, Z. W., Simons, M., & Hla, T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412172111 · Cited by 82
Chimal-Ramírez, G. K., Espinoza‐Sánchez, N. A., & Fuentes‐Pananá, E. M. (2013) · Journal of Oncology · doi:10.1155/2013/835956 · Cited by 88
Chen, T., Wu, C., Wang, C., Hsu, W., Yang, T., Lou, P., Ko, J., & Chang, Y. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.08.011 · Cited by 77
Acute Limb Ischemia—Much More Than Just a Lack of Oxygen
Simon, F., Oberhuber, A., Floros, N., Busch, A., Wagenhäuser, M. U., Schelzig, H., & Duran, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020374 · Cited by 83
Zebrafish embryo, a tool to study tumor angiogenesis
Tobia, C., Sena, G. D., & Presta, M. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103238ct · Cited by 91
Ischemic heart diseases: Current treatments and future
Choi, D., Hwang, K.-C., Lee, K. Y., & Kim, Y.-H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.016 · Cited by 93
Wang, C., Weihrauch, D., Schwabe, D., Bienengraeber, M., Warltier, D. C., Kersten, J. R., Pratt, P. F., & Pagel, P. S. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000226094.94877.98 · Cited by 81
Connexin43 deficiency causes dysregulation of coronary vasculogenesis
Walker, D. L., Vacha, S. J., Kirby, M. L., & Lo, C. W. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.06.004 · Cited by 83
The von Hippel–Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis
Barry, R. E., & Krek, W. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.008 · Cited by 86
Leukemia regression by vascular disruption and antiangiogenic therapy
Madlambayan, G. J., Meacham, A. M., Hosaka, K., Mir, S., Jorgensen, M., Scott, E. W., Siemann, D. W., & Cogle, C. R. (2010) · Blood · doi:10.1182/blood-2009-06-230474 · Cited by 75
Fu, S., He, S.-Y., Xu, B., Hu, C., Lu, S.-F., Shen, W., Huang, Y., Hong, H., Li, Q., Wang, N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094604 · Cited by 75
Glucose, Insulin, and Oxygen Interplay in Placental Hypervascularisation in Diabetes Mellitus
Cvitic, S., Desoye, G., & Hiden, U. (2014) · BioMed Research International · doi:10.1155/2014/145846 · Cited by 75
Kozberg, M. G., Ma, Y., Shaik, M. A., Kim, S. H., & Hillman, E. M. C. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2363-15.2016 · Cited by 75
Schweizer, R. M., Velotta, J. P., Ivy, C. M., Jones, M. R., Muir, S. M., Bradburd, G. S., Storz, J. F., Scott, G. R., & Cheviron, Z. A. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008420 · Cited by 80
Novel Therapeutic Targets for Hypoxia-Related Cardiovascular Diseases: The Role of HIF-1
Liu, M., Galli, G. L. J., Wang, Y., Fan, Q., Wang, Z., Wang, X., & Xiao, W. L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00774 · Cited by 76
Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells
Anfossi, G., Russo, I., Doronzo, G., Pomero, A., & Trovati, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/174341 · Cited by 73
Sakagami, H., Hashimoto, K., Suzuki, F., Ogiwara, T., Satoh, K., Ito, H., Hatano, T., Yoshida, T., & Fujisawa, S.-I. (2005) · Phytochemistry · doi:10.1016/j.phytochem.2005.05.013 · Cited by 74
Mendichovszky, I. A., & Jackson, A. (2011) · British Journal of Radiology · doi:10.1259/bjr/82292521 · Cited by 76
Succinate Dehydrogenase-deficient Tumors: Diagnostic Advances and Clinical Implications
Barletta, J. A., & Hornick, J. L. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31825c6bc6 · Cited by 79
Goswami, A. G., Basu, S., Huda, F., Pant, J., Kar, A. G., Banerjee, T., & Shukla, V. K. (2022) · Growth Factors · doi:10.1080/08977194.2022.2074843 · Cited by 83
A New Paradigm for the Treatment of Alzheimer's Disease: Targeting Vascular Activation
Grammas, P., Martinez, J. M., Sanchez, A. C., Yin, X., Riley, J., Gay, D., Desobry, K., Tripathy, D., Luo, J., Evola, M., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-2014-132057 · Cited by 77
Beischlag, T. V., Taylor, R. T., Rose, D. W., Yoon, D., Chen, Y., Lee, W.-H., Rosenfeld, M. G., & Hankinson, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410456200 · Cited by 74
CSB protein is (a direct target of HIF‐1 and) a critical mediator of the hypoxic response
Filippi, S., Latini, P., Frontini, M., Palitti, F., Egly, J., & Proietti‐De‐Santis, L. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.180 · Cited by 82
Antiangiogenic Effects of Coumarins against Cancer: From Chemistry to Medicine
Majnooni, M. B., Fakhri, S., Smeriglio, A., Trombetta, D., Croley, C. R., Bhattacharyya, P., Sobarzo‐Sánchez, E., Farzaei, M. H., & Bishayee, A. (2019) · Molecules · doi:10.3390/molecules24234278 · Cited by 82
Puppo, M., Battaglia, F., Ottaviano, C., Delfino, S., Ribatti, D., Varesio, L., & Bosco, M. C. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2059 · Cited by 76
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
Luttun, A., Autiero, M., Tjwa, M., & Carmeliet, P. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.09.002 · Cited by 84
Measuring tumour vascular response to antivascular and antiangiogenic drugs
Tozer, G. M. (2003) · British Journal of Radiology · doi:10.1259/bjr/30165281 · Cited by 74
Li, X., & O’Donoghue, J. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.037 · Cited by 70
Chae, S., Paik, J., Allende, M. L., Proia, R. L., & Hla, T. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.01.001 · Cited by 72
Abaci, H. E., Shen, Y.-I., Tan, S., & Gerecht, S. (2014) · Scientific Reports · doi:10.1038/srep04951 · Cited by 71
Martorell, L., Gentile, M., Rius, J., Rodríguez, C., Crespo, J., Badimón, L., & Martínez‐González, J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00945-09 · Cited by 79
Park, S., Bae, I., & Lee, Y. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21588 · Cited by 81
Zhang, P., Tchou-Wong, K.-M., & Costa, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1525 · Cited by 82
Shi, D., Guo, W., Chen, W., Fu, L., Wang, J., Tian, Y., Xiao, X., Kang, T., Huang, W., & Deng, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043898 · Cited by 88
Genomic Function of Estrogen Receptor β in Endometriosis
Han, S. J., Lee, J. E., Cho, Y. J., Park, M. J., & O’Malley, B. W. (2019) · Endocrinology · doi:10.1210/en.2019-00442 · Cited by 88
Therapeutic angiogenesis-based strategy for peripheral artery disease
Han, J., Luo, L., Marcelina, O., Kasim, V., & Wu, S. (2022) · Theranostics · doi:10.7150/thno.74785 · Cited by 80
Signaling pathways in liver cancer: pathogenesis and targeted therapy
Xue, Y., Ruan, Y., Wang, Y., Xiao, P., & Xu, J. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00184-0 · Cited by 97
Warrington, J. P., Csiszar, A., Mitschelen, M., Lee, Y. W., & Sonntag, W. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030444 · Cited by 71
Age-related changes in brain support cells: Implications for stroke severity
Sohrabji, F., Bake, S., & Lewis, D. K. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.013 · Cited by 70
Charlot, C., Dubois‐Pot‐Schneider, H., Serchov, T., Tourrette, Y., & Wasylyk, B. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-738-9_1 · Cited by 91
Siemann, D. W., Chaplin, D. J., & Horsman, M. R. (2017) · Cancer Investigation · doi:10.1080/07357907.2017.1364745 · Cited by 78
Molecular Regulation of Sprouting Angiogenesis
Duran, C. L., Howell, D. W., Dave, J. M., Smith, R. L., Torrie, M. E., Essner, J. J., & Bayless, K. J. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160048 · Cited by 86
Scott, A., Vadalasetty, K. P., Łukasiewicz, M., Jaworski, S., Wierzbicki, M., Chwalibóg, A., & Sawosz, E. (2017) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12754 · Cited by 70
Chuang, T.-J., Lin, K., Chio, C., Wang, C.-C., Chang, C.-P., & Kuo, J. (2012) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e318265d128 · Cited by 75
VEGFR1 and VEGFR2 in Alzheimer’s Disease
Harris, R., Miners, J. S., Allen, S. J., & Love, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170745 · Cited by 72
HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer
Jarman, E. J., Ward, C., Turnbull, A., Martínez-Pérez, C., Meehan, J., Xintaropoulou, C., Sims, A. H., & Langdon, S. P. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1097-0 · Cited by 80
Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol
Hagen, T., D’Amico, G., Quintero, M., Palacios‐Callender, M., Hollis, V., Lam, F., & Moncada, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.204 · Cited by 77
Mehrabani, M., Najafi, M., Kamarul, T., Mansouri, K., Iranpour, M., Nematollahi, M. H., Ghazi‐Khansari, M., & Sharifi, A. M. (2015) · Cell Proliferation · doi:10.1111/cpr.12209 · Cited by 75
Guadall, A., Orriols, M., Rodríguez‐Calvo, R., Calvayrac, O., Crespo, J., Aledo, R., Martínez‐González, J., & Rodríguez, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162917 · Cited by 71
Mechanism of Cancer Cell Adaptation to Metabolic Stress
Liu, R. R., Li, Z., Bai, S., Zhang, H., Tang, M., Lei, Y., Chen, L., Liang, S., Zhao, Y., Wei, Y., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800195-mcp200 · Cited by 72
Wang, H., Yang, Z., Jiang, Y., & Hartnett, M. E. (2014) · PubMed Central · Cited by 77
Zhang, J., Guan, J., Qi, X., Ding, H., Yuan, H., Xie, Z., Chen, C., Li, X., Zhang, C., & Huang, Y. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14025 · Cited by 69
HIF-1α Metabolic Pathways in Human Cancer
Elzakra, N., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51652-9_17 · Cited by 74
Influence of low oxygen tensions on macrophage polarization
Escribese, M. M., Casas, M., & Corbí, A. L. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.002 · Cited by 79
Metadata
- Authors
- Pugh, C. W., & Ratcliffe, P. J.
- Corresponding author
- Ratcliffe, Peter J
- Venue
- Nature Medicine
- Published
- 2003-06
- Volume
- 9
- Issue
- 6
- Pages
- 677-684
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2013818100
- Cited by
- 2,520
- References
- 121
- Citations by year
- 2026: 42 · 2025: 70 · 2024: 98 · 2023: 106 · 2022: 111 · 2021: 106 · 2020: 108 · 2019: 117 · 2018: 91 · 2017: 118 · 2016: 110 · 2015: 116 · 2014: 130 · 2013: 138 · 2012: 121
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- angiogenesis, hypoxia, hypoxia-inducible factor, dioxygenase, oxygen sensing, transcriptional regulation, developmental angiogenesis, tumor angiogenesis, tumor phenotype
- MeSH terms
- Animals, Hypoxia, DNA-Binding Proteins, Humans, Hydroxylation, Neoplasms, Neovascularization, Pathologic, Nuclear Proteins, Transcription Factors, Gene Expression Regulation, Developmental, Neovascularization, Physiologic, Protein Isoforms, Protein Subunits, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.